Amneal Pharmaceuticals Inc Class A (AMRX)
Interest Expense
$227.46M
TTM · Period ending: · USD
AMRX Interest Expense
Latest reported$227.46Mperiod ending
Latest reported$227.46Mperiod ending
AMRX Interest Expense ($0.00 → $227.46M)
Annual interest expense
High-resolution chart · PNG
AMRX interest expense history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Interest Expense (USD) |
|---|---|
| 241,091,000 | |
| 258,595,000 | |
| 210,629,000 | |
| 158,377,000 | |
| 136,325,000 | |
| 145,998,000 | |
| 168,205,000 | |
| 143,571,000 | |
| 71,061,000 | |
| 55,283,000 | |
| 0 | |
| 0 |